| # | Drug | Count |
|---|---|---|
| 0 | ADALIMUMAB | 24 |
| 1 | SECUKINUMAB | 10 |
| 2 | INFLIXIMAB | 8 |
| 3 | PREDNISONE | 7 |
| 4 | CERTOLIZUMAB PEGOL | 6 |
| 5 | DICLOFENAC SODIUM | 6 |
| 6 | PANTOPRAZOLE SODIUM | 6 |
| 7 | ALBUTEROL SULFATE | 5 |
| 8 | AMBRISENTAN | 5 |
| 9 | ERGOCALCIFEROL | 5 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | TOFERSEN | 1 | 0.0018 |
| 1 | CLOFARABINE | 3 | 0.0013 |
| 2 | RASBURICASE | 3 | 0.0012 |
| 3 | DICLOXACILLIN SODIUM | 1 | 0.0011 |
| 4 | INFLIXIMAB-DYYB | 3 | 0.0009 |
| 5 | ZIPRASIDONE | 3 | 0.0008 |
| 6 | IRON DEXTRAN | 1 | 0.0007 |
| 7 | VANCOMYCIN HYDROCHLORIDE | 5 | 0.0006 |
| 8 | AMIKACIN SULFATE | 1 | 0.0006 |
| 9 | MARAVIROC | 1 | 0.0004 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | CCR5 Co-receptor Antagonist [EPC] | 1 | 0.0004 |
| 1 | Interleukin-17A Antagonist [EPC] | 11 | 0.0003 |
| 2 | Hydrolytic Lysosomal Glycogen-specific Enzyme [EPC] | 1 | 0.0003 |
| 3 | CD33-directed Immunoconjugate [EPC] | 1 | 0.0003 |
| 4 | Sulfonamide Antibacterial [EPC] | 1 | 0.0003 |
| 5 | Lipid-based Polyene Antifungal [EPC] | 3 | 0.0002 |
| 6 | Provitamin D2 Compound [EPC] | 5 | 0.0002 |
| 7 | Hydrolytic Lysosomal Glycosaminoglycan-specific Enzyme [EPC] | 2 | 0.0001 |
| 8 | Oxazolidinone Antibacterial [EPC] | 4 | 0.0001 |
| 9 | Bile Acid [EPC] | 3 | 0.0001 |